ACS    Age-related differences in virtual histology-intravascular ultrasound findings in patients with coronary artery disease J Cardiol, 2010. 55(2): p. 224-231. Y. J. Hong, et al., Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction Eur Heart J, 2010. N. Vuilleumier, et al., Aspects on the intensity and the relief of pain in the prehospital phase of acute coronary syndrome: experiences from a randomized clinical trial Coron Artery Dis, 2010. 21(2): p. 113-20. C. Zedigh, et al., Aspirin administration in ED patients who presented with undifferentiated chest pain: age, race, and sex effects Am J Emerg Med, 2010. 28(3): p. 318-24. K. M. Takakuwa, F. S. Shofer and J. E. Hollander, Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndrome Int J Cardiol, 2010. X. L. Shen, et al., Characteristics and outcome of patients with acute coronary syndrome and normal or near-normal coronary angiography Coron Artery Dis, 2010. S. Minha, et al., Clinical outcome after acute coronary syndrome in Japanese patients: An observational cohort study J Cardiol, 2010. 55(1): p. 69-76. M. Nakamura, et al., A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents EuroIntervention, 2010. 5(7): p. 841-6. S. Rathore, et al., Coronary Artery Calcium Scoring in the Emergency Department: Identifying Which Patients With Chest Pain Can Be Safely Discharged Home Ann Emerg Med, 2010. F. Nabi, et al., Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial Ann Intern Med, 2010. 152(4): p. 211-7. S. Toh, et al., Coronary Revascularization Strategy for ST Elevation Myocardial Infarction with Multivessel Disease: Experience and Results at 1-Year Follow-Up Am J Ther, 2010. T. Mohamad, et al., Coronary score adds prognostic information for patients with acute coronary syndrome Circ J, 2010. 74(3): p. 490-5. G. Huang, et al., Correlation of thrombolysis in myocardial infarction (TIMI) risk score with extent of coronary artery disease in patients with acute coronary syndrome J Pak Med Assoc, 2010. 60(3): p. 197-200. M. S. Lakhani, et al., Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38 Circulation, 2010. 121(1): p. 71-9. E. M. Mahoney, et al., CYP1A1 MSPI (T6235C) gene polymorphism is associated with mortality in acute coronary syndrome patients Clin Exp Pharmacol Physiol, 2010. 37(2): p. 193-8. M. D. Jarvis, et al., Differences in mortality in acute coronary syndrome symptom clusters Am Heart J, 2010. 159(3): p. 392-8. B. Riegel, et al., Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events Int J Cardiol, 2010. I. Porto, et al., Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use J Cardiovasc Pharmacol Ther, 2010. 15(1): p. 47-52. M. H. Hoskins, et al., Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial Lancet, 2010. K. Rasmussen, et al., Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients Scand Cardiovasc J, 2010. 44(2): p. 69-75. K. Vikenes, et al., Eosinophil cationic protein: A new biomarker of coronary atherosclerosis Atherosclerosis, 2010. G. Niccoli, et al., Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events Eur Heart J, 2010. J. Lopez-Sendon, et al., Gender differences in the treatment of non-ST-segment elevation myocardial infarction Clin Cardiol, 2010. 33(2): p. 99-103. D. Tavris, et al., Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction Heart, 2010. 96(6): p. 453-9. S. S. Lawesson, et al., [Peculiarities of Dynamics and Prognostic Value of NT-proBNP Level in Different Variants of Treatment of Patients With Acute Coronary Syndrome.] Kardiologiia, 2010. 50(2): p. 15-20. E. V. Shreider, et al., Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome Atherosclerosis, 2010. 209(1): p. 300-5. N. Taglieri, et al., Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome Cell Stress Chaperones, 2010. X. Zhang, et al., Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement J Cardiovasc Med (Hagerstown), 2010. 11(1): p. 7-13. C. Lazzeri, et al., Pre-hospital ECG for acute coronary syndrome in urban India: A cost-effectiveness analysis BMC Cardiovasc Disord, 2010. 10(1): p. 13. J. Schulman-Marcus, D. Prabhakaran and T. A. Gaziano, Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation, 2010. 121(1): p. 43-51. S. J. Pocock, et al., Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients Coron Artery Dis, 2010. R. M. Roman, et al., Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort J Invest Dermatol, 2010. 130(4): p. 962-7. M. Wakkee, R. M. Herings and T. Nijsten, Relationship between serum vasoactive factors and plaque morphology in patients with non-ST-segment elevated acute coronary syndrome Chin Med J (Engl), 2010. 123(2): p. 193-7. Y. F. Lu, S. Z. Lu and Y. D. Chen, Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation Arterioscler Thromb Vasc Biol, 2010. 30(3): p. 634-40. W. H. Tang, et al., Towards risk stratification in systemic atherosclerosis: value of myocardial function and viability imaging as an adjunct to MR angiography Eur Radiol, 2010. 20(4): p. 838-45. A. Seeger, et al., Treatment with 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients with Recent Acute Coronary Syndrome Circ Cardiovasc Imaging, 2010. J. C. Tardif, et al., Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial Circulation, 2009. 119(15): p. 2032-9. D. A. Morrow, et al., Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction Circulation, 2009. 119(21): p. 2758-64. D. A. Morrow, et al., Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score Circulation, 2009. 119(14): p. 1873-82. S. Subherwal, et al., Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice Circulation, 2009. 119(18): p. 2454-62. T. Y. Wang, et al., Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure Eur Heart J, 2009. 30(3): p. 338-45. P. Abrahamsson, et al., Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Eur Heart J, 2009. 30(6): p. 655-61. A. Budaj, et al., Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias Eur Heart J, 2009. 30(6): p. 645-54. A. Hirsch, et al., Prognostic value of circulating chromogranin A levels in acute coronary syndromes Eur Heart J, 2009. 30(1): p. 25-32. A. M. Jansson, et al., Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J, 2009. 30(12): p. 1457-66. R. Mehran, et al., Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial Eur Heart J, 2009. 30(14): p. 1753-63. A. D. Michelson, et al., Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells Eur Heart J, 2009. 30(5): p. 584-93. K. Stellos, et al., Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study Eur Heart J, 2009. 30(11): p. 1348-55. A. Tanaka, et al., Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction Eur Heart J, 2009. 30(5): p. 549-57. J. A. Wong, et al., Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromes Eur Heart J, 2009. 30(15): p. 1844-52. K. Yunoki, et al., A comparison between B-type natriuretic peptide, global registry of acute coronary events (GRACE) score and their combination in ACS risk stratification Heart, 2009. 95(22): p. 1836-42. D. S. Ang, et al., Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events Heart, 2009. 95(11): p. 888-94. D. Brieger, et al., Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events Heart, 2009. 95(1): p. 20-6. S. Dey, et al., Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database Heart, 2009. 95(3): p. 221-7. C. P. Gale, et al., Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes Heart, 2009. 95(17): p. 1442-8. K. E. Joynt, et al., Simple point-of-care risk stratification in acute coronary syndromes: the AMIS model Heart, 2009. 95(8): p. 662-8. D. J. Kurz, et al., Secondhand smoke exposure and survival following acute coronary syndrome: prospective cohort study of 1261 consecutive admissions among never-smokers Heart, 2009. 95(17): p. 1415-8. J. P. Pell, et al., Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study Heart, 2009. 95(23): p. 1937-43. K. Rahimi, et al., Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial Heart, 2009. 95(6): p. 468-75. J. Redfern, et al., Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes Heart, 2009. 95(10): p. 807-12. R. K. Riezebos, et al., Pregnancy in high risk cardiac conditions Heart, 2009. 95(8): p. 680-6. J. W. Roos-Hesselink, J. J. Duvekot and S. A. Thorne, Delay to angiography and outcomes following presentation with high-risk, non-ST-elevation acute coronary syndromes: results from the Global Registry of Acute Coronary Events Heart, 2009. 95(3): p. 211-5. N. Swanson, et al., Chest pain in the emergency department: role of cardiac imaging Heart, 2009. 95(12): p. 1023-30. F. J. Wackers, Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial J Am Coll Cardiol, 2009. 54(15): p. 1438-46. G. Dangas, et al., Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome J Am Coll Cardiol, 2009. 54(4): p. 357-64. K. M. Eggers, et al., Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial J Am Coll Cardiol, 2009. 53(23): p. 2186-96. A. E. Fraley, et al., Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study) J Am Coll Cardiol, 2009. 54(4): p. 293-302. T. Hiro, et al., Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial J Am Coll Cardiol, 2009. 53(18): p. 1642-50. U. Hoffmann, et al., Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial J Am Coll Cardiol, 2009. 54(5): p. 468-76. S. S. Jolly, et al., Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol, 2009. 53(12): p. 1021-30. R. D. Lopes, et al., Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome J Am Coll Cardiol, 2009. 54(1): p. 49-57. S. Motoyama, et al., Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol, 2009. 54(14): p. 1293-302. E. Nikolsky, et al., The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis J Am Coll Cardiol, 2009. 54(8): p. 678-85. M. O'Donoghue, et al., Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol, 2009. 54(5): p. 477-86. A. Prasad, et al., Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial J Am Coll Cardiol, 2009. 53(16): p. 1411-21. B. M. Scirica, et al., Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia J Am Coll Cardiol, 2009. 54(13): p. 1165-72. P. Venge, et al., Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation J Am Coll Cardiol, 2009. 54(15): p. 1434-7. D. D. Waters and I. Ku, Sex differences in mortality following acute coronary syndromes JAMA, 2009. 302(8): p. 874-82. J. S. Berger, et al., Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome JAMA, 2009. 301(9): p. 937-44. P. M. Ho, et al., Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial JAMA, 2009. 302(9): p. 947-54. G. Montalescot, et al., Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial Lancet, 2009. 374(9683): p. 29-38. J. L. Mega, et al., Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial Lancet, 2009. 374(9692): p. 787-95. M. S. Sabatine, et al., Early versus delayed, provisional eptifibatide in acute coronary syndromes N Engl J Med, 2009. 360(21): p. 2176-90. R. P. Giugliano, et al., Early versus delayed invasive intervention in acute coronary syndromes N Engl J Med, 2009. 360(21): p. 2165-75. S. R. Mehta, et al., Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med, 2009. 361(11): p. 1045-57. L. Wallentin, et al., The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale Am Heart J, 2009. 158(3): p. 327-334 e4. . Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) Am Heart J, 2009. 157(1): p. 141-8. N. Akhter, et al., Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiative Am Heart J, 2009. 158(5): p. 748-754 e1. E. A. Amsterdam, et al., Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities Am Heart J, 2009. 158(1): p. 133-40. D. S. Ang, et al., Blood pressure paradox in patients with non-ST-segment elevation acute coronary syndromes: results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) quality improvement initiative Am Heart J, 2009. 157(3): p. 525-31. S. Bangalore, et al., Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study Am Heart J, 2009. 157(3): p. 509-516 e1. Y. Bi, et al., The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative Am Heart J, 2009. 158(2): p. 263-70. M. G. Cohen, et al., Acute coronary syndrome emergency treatment strategies: Improved treatment and reduced mortality in patients with acute coronary syndrome using guideline-based critical care pathways Am Heart J, 2009. 157(1): p. 61-8. J. C. Corbelli, et al., Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: results of the STACK-on to ENOXaparin (STACKENOX) study Am Heart J, 2009. 158(2): p. 177-84. L. Drouet, C. Bal dit Sollier and J. Martin, Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada Am Heart J, 2009. 158(3): p. 392-9. B. Elbarouni, et al., The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes Am Heart J, 2009. 158(2): p. 193-201 e1-5. S. G. Goodman, et al., Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study Am Heart J, 2009. 157(4): p. 733-9. Y. Han, et al., Use of beta-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: are we on target? Am Heart J, 2009. 158(3): p. 378-85. M. Herman, et al., Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial Am Heart J, 2009. 157(4): p. 599-605. S. James, et al., Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk Am Heart J, 2009. 157(3): p. 502-8. C. D. Joyner, et al., Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events Am Heart J, 2009. 157(6): p. 1097-105. K. S. Pieper, et al., Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy Am Heart J, 2009. 158(3): p. e21-6. Y. B. Pride, et al., Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes Am Heart J, 2009. 157(4): p. 642-50 e1. R. V. Rao, et al., Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial Am Heart J, 2009. 157(5): p. 845-52. M. J. Sculpher, et al., Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes Am Heart J, 2009. 157(4): p. 740-5. H. Tizon-Marcos, et al., Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography Am Heart J, 2009. 157(4): p. 716-23. T. Y. Wang, et al., Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial Am Heart J, 2009. 158(3): p. 386-91. S. R. Wilson, et al., Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial Am Heart J, 2009. 157(1): p. 60 e1-9. G. Yong, et al., Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study Am Heart J, 2009. 158(4): p. 509-512 e1. S. P. Zhao, et al., Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes Am J Cardiol, 2009. 103(7): p. 959-68. G. S. Abela, et al., Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome Am J Cardiol, 2009. 104(10): p. 1324-9. N. M. Allen LaPointe, et al., Safety of contrast in stress echocardiography in stable patients and in patients with suspected acute coronary syndrome but negative 12-hour troponin Am J Cardiol, 2009. 104(1): p. 14-8. B. Anantharam, et al., Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes Am J Cardiol, 2009. 103(11): p. 1530-6. A. J. Bagnall, et al., Comparison of outcomes in patients > or =70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome Am J Cardiol, 2009. 104(5): p. 624-9. R. Bagur, et al., Usefulness of age and gender in the early triage of patients with acute chest pain having cardiac computed tomographic angiography Am J Cardiol, 2009. 104(9): p. 1165-70. F. Bamberg, et al., Effect of blood hematocrit and erythrocyte deformability on adenosine 5'-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy Am J Cardiol, 2009. 104(6): p. 764-8. E. Cecchi, et al., Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients Am J Cardiol, 2009. 104(8): p. 1078-82. T. Cuisset, et al., Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes Am J Cardiol, 2009. 104(9): p. 1171-8. J. P. Depta, et al., Impact of admission glucose level and presence of diabetes mellitus on mortality in patients with non-ST-segment elevation acute coronary syndrome treated conservatively Am J Cardiol, 2009. 103(7): p. 954-8. A. Dziewierz, et al., Comparison of men and women with acute coronary syndrome in six Middle Eastern countries Am J Cardiol, 2009. 104(8): p. 1018-22. A. El-Menyar, et al., Usefulness of diabetes mellitus to predict long-term outcomes in patients with unstable angina pectoris Am J Cardiol, 2009. 104(4): p. 492-7. M. E. Farkouh, et al., Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis) Am J Cardiol, 2009. 104(1): p. 36-40. C. M. Gibson, et al., Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]) Am J Cardiol, 2009. 103(5): p. 598-603. R. J. Goldberg, et al., Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]) Am J Cardiol, 2009. 103(2): p. 175-80. J. M. Gore, et al., Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus Am J Cardiol, 2009. 103(6): p. 772-8. T. Hasin, et al., Prognostic value of admission fasting glucose levels in patients with acute coronary syndrome Am J Cardiol, 2009. 104(4): p. 470-4. L. Kolman, et al., Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial) Am J Cardiol, 2009. 103(9): p. 1196-203. A. J. Lansky, et al., Prognostic impact of types of atrial fibrillation in acute coronary syndromes Am J Cardiol, 2009. 104(10): p. 1317-23. D. H. Lau, et al., Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome Am J Cardiol, 2009. 104(5): p. 638-43. R. M. LeLeiko, et al., Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY) Am J Cardiol, 2009. 104(10): p. 1330-5. J. P. Linefsky, et al., Severity of coronary arterial stenoses responsible for acute coronary syndromes Am J Cardiol, 2009. 103(9): p. 1183-8. G. Manoharan, et al., Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome Am J Cardiol, 2009. 104(2): p. 175-81. C. Melloni, et al., Anemia for risk assessment of patients with acute coronary syndromes Am J Cardiol, 2009. 103(4): p. 442-7. N. Meneveau, et al., Effect of culprit-lesion remodeling versus plaque rupture on three-year outcome in patients with acute coronary syndrome Am J Cardiol, 2009. 103(6): p. 791-5. H. Okura, et al., Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes Am J Cardiol, 2009. 103(3): p. 295-300. B. A. Olenchock, et al., Comparison of the effects of ramipril versus telmisartan on high-sensitivity C-reactive protein and endothelial progenitor cells after acute coronary syndrome Am J Cardiol, 2009. 103(11): p. 1500-5. I. Porto, et al., Effectiveness of myocardial perfusion scintigraphy to predict coronary anatomy in patients with non-ST elevation acute coronary syndrome Am J Cardiol, 2009. 104(5): p. 644-7. B. J. Potter, et al., Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome Am J Cardiol, 2009. 104(6): p. 750-7. J. Rodes-Cabau, et al., Arterial access-site-related outcomes of patients undergoing invasive coronary procedures for acute coronary syndromes (from the ComPaRison of Early Invasive and Conservative Treatment in Patients With Non-ST-ElevatiOn Acute Coronary Syndromes [PRESTO-ACS] Vascular Substudy) Am J Cardiol, 2009. 103(6): p. 796-800. A. Sciahbasi, et al., Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphology Am J Cardiol, 2009. 103(3): p. 307-11. Z. Syed, et al., Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes Am J Cardiol, 2009. 103(2): p. 187-93. C. Tamburino, et al., Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study) Am J Cardiol, 2009. 103(8): p. 1056-60. P. Tung, et al., Relation of body mass index to mortality after development of heart failure due to acute coronary syndrome Am J Cardiol, 2009. 103(12): p. 1736-40. A. H. Wu, et al., Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention Am J Cardiol, 2009. 104(4): p. 519-24. J. Xinwei, et al., Clinical significance of borderline elevated troponin I levels across different assays in patients with suspected acute coronary syndrome Am J Cardiol, 2009. 104(2): p. 164-8. M. Zahid, et al., Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy Catheter Cardiovasc Interv, 2009. 73(7): p. 866-70. L. Bonello, et al., Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes Catheter Cardiovasc Interv, 2009. 74(3): p. 408-15. M. De Carlo, et al., Is computed tomography coronary angiography the most accurate and effective noninvasive imaging tool to evaluate patients with acute chest pain in the emergency department? CT coronary angiography is the most accurate and effective noninvasive imaging tool for evaluating patients presenting with chest pain to the emergency department: antagonist viewpoint Circ Cardiovasc Imaging, 2009. 2(3): p. 264-75; discussion 275. R. C. Hendel, Is computed tomography coronary angiography the most accurate and effective noninvasive imaging tool to evaluate patients with acute chest pain in the emergency department?: CT coronary angiography is the most accurate and effective noninvasive imaging tool for evaluating patients presenting with chest pain to the emergency department Circ Cardiovasc Imaging, 2009. 2(3): p. 251-63; discussion 263. U. Hoffmann and F. Bamberg, Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation, 2009. 119(5): p. 687-98. J. Aoki, et al., Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program Circulation, 2009. 120(7): p. 560-7. E. S. Brilakis, et al., Soluble CXCL16 predicts long-term mortality in acute coronary syndromes Circulation, 2009. 119(25): p. 3181-8. A. M. Jansson, et al., Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up Circulation, 2009. 119(2): p. 237-42. R. Marcucci, et al.,